Week of June 25, 2024 | Vol. 13, Issue 26

Upcoming Events

Industry Activity

M&A Transactions

Featured Chart

Employers Increasingly Including GLP-1 Drugs as a Covered Benefit for Weight Loss

Source: Foundation of Employee Benefit Plans (Survey Data; June 2024) and Bourne Partners

Trading Comps

Market Research

M&A Pipeline

For more information about our active deals, please reach out to the following:

Pharmaceuticals



Robert Stanley

Director

Carson Riley

Vice President

Pharma Services



Todd Bokus

Director

Jake Curtis

Vice President

Healthcare & Pharmacy Services

Aaron Olson

Managing Director, Head of Healthcare Services

Featured Headlines

Sharecare enters into definitive agreement to be acquired by Altaris

Sharecare

Private equity invests in trial sites as CRO consolidation continues: PitchBook

Fierce Biotech

Acquisition of Emergent BioSolutions’ sterile manufacturing facility in Camden, Maryland will allow Bora to provide Sterile Fill/Finish Services.

Bora Pharmaceuticals

How A.I. Is Revolutionizing Drug Development

The New York Times

Abzena and Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

PR Newswire

Takeda Makes $75M Equity Investment in Ascentage Pharma

Contract Pharma

Recent Transactions

Bourne continues to be one of the most active Pharma Services Advisors, having closed 7 transactions with 7 different sponsors within the last 45 days with more to come! Select recent clients and counterparties include: